possible side effects of semaglutide Week by Week: Pharmacist's Timeline New Side Effects of Semaglutide

INTRODUCTION Glucagonlike peptide1 receptor agonists (GLP1 RAs) have become a cornerstone in treating type 2 diabetes (T2D) and obesity, 1 with their application rapidly expanding

GLP-1 medications typically cause gastrointestinal side effectsnausea, vomiting, constipation, and diarrheaespecially during dose escalation

The costs vary, based on things like whether you have private insurance coverage, manufacturer patient support programs, dosage, and the province that youre in

PlexusDx typically considers candidates with a BMI of 30 or higher, or a BMI of 27 to 29.9 with at least one weight-related health condition such as high blood pressure or type 2 diabetes

It is distinct from Rybelsus, which is lower-dose oral semaglutide for type 2 diabetes, and, following MHRA approval in June 2026, is rolling out on private prescription during the second half of 2026 rather than on the NHS